輸入代號或公司名稱後按 Enter
8409

商之器

-0.10 (-0.55%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
18.102成交張數17.75本益比1.93股價淨值比0.00%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q2-0.581.01-0.19-51.9%-5.99%11.62%
2026Q1-0.050.97-0.02-3.0%-0.48%10.27%
2025Q40.82-59.6%0.240.2631.8%8.65%2.47%
2025Q30.821.450.2623.2%9.56%17.20%
2025Q2-0.620.35-0.20-59.6%-7.23%4.21%
2025Q1-0.78-0.02-0.25-107.3%-8.29%-0.31%
2024Q42.0399.0%0.070.6536.4%23.11%0.69%
2024Q3-0.28-0.94-0.09-18.5%-3.54%-11.45%
2024Q2-0.99-1.09-0.32-114.2%-11.66%-12.78%
2024Q1-0.69-0.56-0.22-81.5%-7.38%-6.05%
2023Q41.02191.4%-0.440.3333.6%11.24%-4.47%
2023Q3-0.43-1.11-0.14-31.6%-4.89%-12.16%
2023Q2-0.46-1.08-0.15-43.7%-5.05%-11.45%
2023Q1-0.57-166.3%-1.30-0.18-57.9%-5.84%-13.00%
2022Q40.35-54.5%0.130.1111.5%3.56%1.27%
2022Q3-0.400.55-0.13-32.4%-4.10%4.84%
2022Q2-0.680.67-0.22-63.8%-6.66%6.46%
2022Q10.860.690.2813.0%8.48%7.29%
2021Q40.7725.4%-0.730.2225.1%7.24%-7.49%
2021Q3-0.28-0.89-0.09-19.7%-3.54%-9.51%
2021Q2-0.66-0.87-0.18-54.0%-7.31%-9.64%
2021Q1-0.56-1.18-0.16-57.8%-6.06%-12.31%
2020Q40.61-36.4%-1.050.1822.9%6.65%-10.42%
2020Q3-0.26-0.70-0.08-17.7%-2.93%-7.50%
2020Q2-0.97-1.26-0.28-93.0%-9.99%-12.70%
2020Q1-0.43-0.54-0.12-18.9%-4.13%-5.13%
2019Q40.963.1%-0.500.2825.2%9.40%-4.58%
2019Q3-0.82-0.53-0.24-73.7%-8.04%-5.29%
2019Q2-0.25-0.36-0.07-15.6%-2.31%-3.28%
2019Q1-0.39-0.48-0.11-23.9%-3.51%-4.28%
2018Q40.94357.1%-0.360.2727.7%8.60%-3.18%
2018Q3-0.65-1.09-0.19-52.2%-6.04%-10.03%
2018Q2-0.37-0.98-0.11-25.9%-3.30%-8.60%
2018Q1-0.27-1.24-0.08-20.9%-2.40%-10.46%
2017Q40.2050.0%-1.470.068.7%1.76%-11.94%
2017Q3-0.55-1.54-0.16-35.4%-4.66%-12.65%
2017Q2-0.62-1.44-0.18-44.4%-5.16%-11.31%
2017Q1-0.51-1.65-0.15-29.3%-4.00%-11.96%
2016Q40.14-2.120.043.7%1.09%
2016Q3-0.45-0.13-21.1%-3.37%